{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:53:44Z","timestamp":1791118424253,"version":"4.1.0"},"reference-count":36,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"abstract":"<jats:p>This study was launched to determine the prognostic significance of local tumor invasiveness (LTI) in 114 patients diagnosed with stage IE\/IIE extranodal natural killer (NK)\/T-cell lymphoma, nasal type (NTCL). LTI was defined as bony invasion or destruction or tumor invasion of the skin. Complete remission (CR), overall survival (OS), and disease-free survival (DFS) were compared between each group according to LTI, Ann Arbor stage, and International Prognostic Index (IPI). LTI was observed in 23 patients. Using multivariate analysis, factors associated with low probability of CR were the presence of LTI (P &amp;lt; .001), the presence of B symptoms (P = .003), and single-modality chemotherapy (P = .045). The presence of LTI (relative risk [RR] = 8.4, 95% confidence interval [CI] 3.9-17.9; P &amp;lt; .001) and high IPI score (RR = 2.8, 95% CI 1.2-6.8; P = .019) were also predictive of OS. The presence of LTI (RR = 7.3, 95% CI 3.2-16.5; P &amp;lt; .001) was an independently significant factor for reduced DFS. Ann Arbor staging system did not predict CR, OS, or DFS but IPI did have predictive power with regard to survival outcome. LTI is the most important prognostic factor in predicting low probability of CR and reduced OS and DFS in nasal stage IE\/IIE NTCL.<\/jats:p>","DOI":"10.1182\/blood-2005-05-2056","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T00:25:16Z","timestamp":1124411116000},"page":"3785-3790","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":155,"title":["Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE\/IIE extranodal NK\/T-cell lymphoma, nasal type"],"prefix":"10.1182","volume":"106","author":[{"given":"Tae Min","family":"Kim","sequence":"first","affiliation":[{"name":"From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Hee","family":"Park","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Yoon","family":"Lee","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Wan","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seock-Ah","family":"Im","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-You","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Seog","family":"Heo","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Jue","family":"Bang","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee-Hyun","family":"Chang","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noe Kyeong","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020071611053917500_REF1","unstructured":"Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 1971;31: 1860-1861."},{"key":"2020071611053917500_REF2","unstructured":"Rosenberg SA. Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas. Cancer Treat Rep. 1977;61: 1023-1027."},{"key":"2020071611053917500_REF3","unstructured":"Danieu L, Wong G, Koziner B, et al. Predictive model for prognosis in advanced diffuse histiocytic lymphoma. Cancer Res. 1986;46: 5372-5379."},{"key":"2020071611053917500_REF4","doi-asserted-by":"crossref","unstructured":"Shipp MA, Harrington DP, Anderson JR, et al. A predictive model for aggressive non-Hodgkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329: 987-994.","DOI":"10.1056\/NEJM199309303291402"},{"key":"2020071611053917500_REF5","doi-asserted-by":"crossref","unstructured":"Ansell SM, Habermann TM, Kurtin PJ, et al. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol. 1997;15: 2296-2301.","DOI":"10.1200\/JCO.1997.15.6.2296"},{"key":"2020071611053917500_REF6","doi-asserted-by":"crossref","unstructured":"Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T\/Natural Killer Cell Lymphomas: efinitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20: 103-111.","DOI":"10.1097\/00000478-199601000-00012"},{"key":"2020071611053917500_","doi-asserted-by":"crossref","unstructured":"Quintanilla-Martinez L, Franklin JL, Guerrero I, et al. Histological and immunophenotypic profile of nasal NK\/T cell lymphomas from Peru: high prevalence of p53 overexpression. Hum Pathol. 1999;30: 849-855.","DOI":"10.1016\/S0046-8177(99)90147-8"},{"key":"2020071611053917500_REF8","doi-asserted-by":"crossref","unstructured":"Gaal K, Sun NC, Hernandez AM, et al. Sinonasal NK\/T-cell lymphomas in the United States. Am J Surg Pathol. 2000;24: 1511-1517.","DOI":"10.1097\/00000478-200011000-00006"},{"key":"2020071611053917500_REF9","unstructured":"Kang YK, Kim BS, Kim TW, et al. Clinicopathologic characteristics of Korean Non-Hodgkin's lymphomas based on REAL classification. J Korean Cancer Assoc. 1999;31: 641-652."},{"key":"2020071611053917500_REF10","doi-asserted-by":"crossref","unstructured":"Ko YH, Ree HJ, Kim WS, et al. Clinicopathologic and genotypic study of extranodal nasal-type natural killer\/T-cell lymphoma and natural killer precursor lymphoma among Koreans. Cancer. 2000;89: 2106-2116.","DOI":"10.1002\/1097-0142(20001115)89:10<2106::AID-CNCR11>3.0.CO;2-G"},{"key":"2020071611053917500_REF11","doi-asserted-by":"crossref","unstructured":"Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet. 1990;335: 128-130.","DOI":"10.1016\/0140-6736(90)90002-M"},{"key":"2020071611053917500_REF12","doi-asserted-by":"crossref","unstructured":"Kanavaros P, Lescs MC, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 1993;81: 2688-2695.","DOI":"10.1182\/blood.V81.10.2688.2688"},{"key":"2020071611053917500_REF13","unstructured":"Lee SY, Park K, Ryoo BR, et al. Korean multicenter study of extranodal NK\/T-cell lymphoma: failure of Ann Arbor staging in predicting prognosis [abstract]. Int J Hematol. 2002;76(suppl 1): 27."},{"key":"2020071611053917500_REF14","doi-asserted-by":"crossref","unstructured":"Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16: 70-77.","DOI":"10.1200\/JCO.1998.16.1.70"},{"key":"2020071611053917500_","doi-asserted-by":"crossref","unstructured":"King AD, Lei KI, Ahuja AT, et al. MR imaging of nasal T-cell\/natural killer cell lymphoma. AJR Am J Roentgenol. 2000;174: 209-211.","DOI":"10.2214\/ajr.174.1.1740209"},{"key":"2020071611053917500_REF16","doi-asserted-by":"crossref","unstructured":"Koom WS, Chung EJ, Yang WI, et al. Angiocentric T-cell and NK\/T-cell lymphomas: radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys. 2004;59: 1127-1137.","DOI":"10.1016\/j.ijrobp.2003.12.006"},{"key":"2020071611053917500_REF17","doi-asserted-by":"crossref","unstructured":"Robbins KT, Fuller LM, Vlasak M, et al. Primary lymphomas of the nasal cavity and paranasal sinuses. Cancer. 1985;56: 814-819.","DOI":"10.1002\/1097-0142(19850815)56:4<814::AID-CNCR2820560419>3.0.CO;2-P"},{"key":"2020071611053917500_REF18","doi-asserted-by":"crossref","unstructured":"Logsdon MD, Ha CS, Kavadi VS, et al. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer. 1997; 80: 477-488.","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<477::AID-CNCR16>3.0.CO;2-U"},{"key":"2020071611053917500_REF19","doi-asserted-by":"crossref","unstructured":"Chim CS, Ma SY, Au WY, et al. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood. 2004;103: 216-221.","DOI":"10.1182\/blood-2003-05-1401"},{"key":"2020071611053917500_REF20","doi-asserted-by":"crossref","unstructured":"Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas: NCI Sponsored International Working Group. J Clin Oncol. 1999;17: 1244-1253.","DOI":"10.1200\/JCO.1999.17.4.1244"},{"key":"2020071611053917500_REF21","doi-asserted-by":"crossref","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958;53: 457-481.","DOI":"10.1080\/01621459.1958.10501452"},{"key":"2020071611053917500_REF22","doi-asserted-by":"crossref","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc [B]. 1972;34: 187-220.","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"2020071611053917500_REF23","doi-asserted-by":"crossref","unstructured":"Liang R, Todd D, Chan TK, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol. 1995;13: 666-670.","DOI":"10.1200\/JCO.1995.13.3.666"},{"key":"2020071611053917500_REF24","doi-asserted-by":"crossref","unstructured":"Cuadra-Garcia I, Proulx GM, Wu CL, et al. Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital. Am J Surg Pathol. 1999;23: 1356-1369.","DOI":"10.1097\/00000478-199911000-00006"},{"key":"2020071611053917500_REF25","doi-asserted-by":"crossref","unstructured":"Abbondanzo SL, Wenig BM. Non-Hodgkin's lymphoma of the sinonasal tract: a clinicopathologic and immunophenotypic study of 120 cases. Cancer. 1995;75: 1281-1291.","DOI":"10.1002\/1097-0142(19950315)75:6<1281::AID-CNCR2820750610>3.0.CO;2-I"},{"key":"2020071611053917500_REF26","doi-asserted-by":"crossref","unstructured":"Li YX, Coucke PA, Li JY, et al. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer. 1998;83: 449-456.","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<449::AID-CNCR13>3.0.CO;2-W"},{"key":"2020071611053917500_REF27","doi-asserted-by":"crossref","unstructured":"You JY, Chi KH, Yang MH, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)\/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol. 2004;15: 618-625.","DOI":"10.1093\/annonc\/mdh143"},{"key":"2020071611053917500_REF28","doi-asserted-by":"crossref","unstructured":"Cheung MM, Chan JK, Lau WH, et al. Early stage nasal NK\/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys. 2002;54: 182-190.","DOI":"10.1016\/S0360-3016(02)02916-4"},{"key":"2020071611053917500_REF29","doi-asserted-by":"crossref","unstructured":"Kern WF, Spier CM, Hanneman EH, et al. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood. 1992;79: 2432-2437.","DOI":"10.1182\/blood.V79.9.2432.2432"},{"key":"2020071611053917500_REF30","doi-asserted-by":"crossref","unstructured":"Kim GE, Cho JH, Yang WI, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol. 2000;18: 54-63.","DOI":"10.1200\/JCO.2000.18.1.54"},{"key":"2020071611053917500_REF31","doi-asserted-by":"crossref","unstructured":"Kim WS, Song SY, Ahn YC, et al. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer\/T-cell lymphoma? Ann Oncol. 2001;12: 349-352.","DOI":"10.1023\/A:1011144911781"},{"key":"2020071611053917500_REF32","doi-asserted-by":"crossref","unstructured":"Ribrag V, Ell Hajj M, Janot F, et al. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia. 2001;15: 1123-1126.","DOI":"10.1038\/sj.leu.2402148"},{"key":"2020071611053917500_REF33","doi-asserted-by":"crossref","unstructured":"Drenou B, Lamy T, Amiot L, et al. CD3-CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Blood. 1997;89: 2966-2974.","DOI":"10.1182\/blood.V89.8.2966"},{"key":"2020071611053917500_REF34","doi-asserted-by":"crossref","unstructured":"Au WY, Lie AK, Liang R, et al. Autologous stem cell transplantation for nasal NK\/T-cell lymphoma: a progress report on its value. Ann Oncol. 2003; 14: 1673-1676.","DOI":"10.1093\/annonc\/mdg458"},{"key":"2020071611053917500_REF35","doi-asserted-by":"crossref","unstructured":"Au WY, Pang A, Choy C, et al. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood. 2004;104: 243-249.","DOI":"10.1182\/blood-2003-12-4197"},{"key":"2020071611053917500_REF36","doi-asserted-by":"crossref","unstructured":"Ohshima K, Suzumiya J, Shimazaki K, et al. Nasal T\/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage. Histopathology. 1997;31: 444-450.","DOI":"10.1046\/j.1365-2559.1997.2880887.x"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/12\/3785\/458282\/zh802305003785.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/12\/3785\/458282\/zh802305003785.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:33:18Z","timestamp":1626395598000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/12\/3785\/109723\/Local-tumor-invasiveness-is-more-predictive-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,1]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-05-2056","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,1]]}}}